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A B S T R A C T
To study genetic changes underlying myxoma virus evolution in its new host, the European
rabbit (Oryctolagus cuniculus), we sequenced selected genomic regions of nine recent
virulent field strains and a live attenuated vaccine strain (‘‘MAV’’, Germany). DNA was
extracted from cell culture passagedmyxoma virus. A total of 4863 bp (approximately 3% of
the genome) of 10 regions spanning 12 genes of the myxoma viruses was sequenced and
compared to the original virulent strain ‘‘Lausanne’’ and its attenuated field derivative strain
‘‘6918’’. The field strains displayed amaximumof three (strains C43, C95) and aminimumof
one (strains CD01, CD05) nucleotide substitutions. These were distributed through all
analysed coding regions, except gene M022L (major envelope protein), where all strains
were identical to ‘‘Lausanne’’ and ‘‘6918’’. Two new single nucleotide insertions were
observed in some of the field strains:within the intergenic regionM014L/M015L andwithin
gene M009L, where it leads to a frameshift. These insertions were located after
homopolymeric regions. The vaccine strain displayed 37 nucleotide substitutions,
predominantly (95%) located in genes M022L and M036L. Interestingly, regions M009L
andM014L/M015Lof thevaccinewerenot amplifiedsuccessfully, suggestingmajorgenomic
changes that couldaccount for itsattenuatedphenotype.Our results support ahighdegreeof
genetic stability of myxoma virus over the past five decades. None of the analysed genome
regions by its own seems sufficient for the genetic characterisation of field strains.
 2009 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
Veterinary Microbiology
journa l homepage: www.e lsev ier .com/ locate /vetmic1. Introduction
Myxomavirus (MV) isa largedouble stranded-DNAvirus
of the genus Leporipoxvirus. In its natural hosts (Sylvilagus* Corresponding author at: ICAV-UP, Rua Padre Armando Quintas,
4485-661 Vaira˜o, Portugal. Tel.: +351 252 660410; fax: +351 252 661780.
E-mail address: amuller@mail.icav.up.pt (A. Muller).
0378-1135/$ – see front matter  2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetmic.2009.07.028brasiliensis and Sylvilagus bachmani) it causes benign
cutaneous fibromas. However, its introduction in the
1950s into a new host, the European rabbit (Oryctolagus
cuniculus), resulted in devastating epizootics withmortality
rates above 99%. Interestingly, within a few years of the
introduction of the virus into naı¨ve European wild rabbit
populations in Australia and Europe, a decrease from the
initial nearly 100% mortality rates were observed. This
processhasbeen related tovirus–host adaptation consisting
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A. Muller et al. / Veterinary Microbiology 140 (2010) 161–166162of the evolution of attenuated viral strains and the natural
selection of resistant rabbits (reviewed by Fenner and Ross,
1994). Extensive knowledge has been gained on subjects
related to this co-evolution, such as the determination of
virulencegradesof circulatingmyxomaviruses (e.g.Ba´rcena
et al., 2000; Fenner and Ross, 1994;Marlier et al., 1999), the
pathogenesis of myxoma virus infection of different clinical
outcomes (Best andKerr, 2000; Best et al., 2000), the rabbits’
immune response (reviewed by Fenner and Ross, 1994), and
the characterisation of virally encoded proteins able to
modulate the host’s immune response and thus clinical
outcome of infection (e.g. Johnston and McFadden, 2003;
Stanford et al., 2007; Willer et al., 1999; Zu´n˜iga, 2002).
Contrasting little is known about the genetic changes
related to the evolution of myxoma virus in its new host
(Kritas et al., 2008; Morales et al., 2008; Saint et al., 2001).
The evolution of poxviruses has been studied based on
whole-genome phylogenetic analyses rather than single
genephylogenydue to theoccurrenceofphenomenasuchas
horizontal gene transfer (Bratke and McLysaght, 2008;
Gubser et al., 2004;HughesandFriedmann,2005;Xingetal.,
2006). To date, the complete genomes of only twomyxoma
viruses are available: the virulent strain ‘‘Lausanne’’,
introduced in 1952 in Europe, and its attenuated field
derivative ‘‘6918’’, obtained in 1995 in Spain (Ba´rcena et al.,
2000; Cameron et al., 1999; Morales et al., 2008). The
comparative analysis of both genomes has identified 73
differences consisting of 67 base substitutions, 4 deletions
and 2 insertions (Morales et al., 2008). Interestingly, events
such as whole gene loss or gain were not observed.
The understanding of genetic changes driving myxoma
virus evolution in the European rabbit requires the genetic
analysis of larger numbers of field strains. The large size of
the viral genome has hampered the availability of this kind
of information, andpartial gene sequences have shown little
if any differences compared to the virulent strain Lausanne
(Kritas et al., 2008; Saint et al., 2001). As gene order and
content remained unchanged in the attenuated myxoma
virus field strain ‘‘6918’’ (Morales et al., 2008), it may be
sufficient to study virus evolution by analysing specific
genomic regions. Our objectives were to study selected
genomic regionsof recentmyxomavirusfield isolates and to
evaluate the suitability of these as molecular marker for
virus evolution within the European rabbit.
2. Materials and methods
2.1. Selection of viral genes
The genome comparison between the virulent myxoma
virus strain ‘‘Lausanne’’ (GenBank accession no. AF170726)
and the attenuated field strain ‘‘9618’’ (GenBank accession
no. AF552530), suggested that the observed disruptions in
ORFsM135R,M148R,M009L,M036Lmay be related to loss
of viral virulence (Morales et al., 2008). Thus, we included
these genome regions in our analysis (Table 1). We also
partially amplified gene M020L to confirm the insertion of
the CTC codon for leucine at position 52 (Morales et al.,
2008). Further five viral genome regions were selected,
which include the following partial genes: M002L/R and
M007L/R for being located in the terminal inverted repeats
A. Muller et al. / Veterinary Microbiology 140 (2010) 161–166 163and encoding immunomodulatory proteins similar to TNF
receptor and to rIFN gamma receptor, respectively
(Johnston and McFadden, 2003; Stanford et al., 2007;
Willer et al., 1999), M014L and M015L, which encode a
kelch-like protein and the small subunit of ribonucleotide
reductase, respectively; M022L encoding the major
envelope protein, as this protein is exposed to the immune
system of the host, and may reflect the effect of immune
pressures; M137R and M138L because the corresponding
sequence of the California myxoma virus strain ‘‘MSD’’
(GenBank accession no. AF030894) was available for
comparison and displayed major differences when com-
pared with ‘‘Lausanne’’ (Jackson et al., 1999). The ‘‘MSD’’
strain naturally infects the brush rabbit (S. bachmani) but
causes fulminant disease in the European rabbit. A further
locus, M061R, coding for the thymidine kinase gene, was
selected for diagnostic purposes only (see below). The term
‘‘genomic region’’ was used to describe the amplified
sequences, which correspond to either part of a single
gene, or, in the case of M014L/M015L and M137R/M138R,
to two adjacent genes and their respective intergenic non-
coding region.
2.2. Primers and sequencing
The targeted genes and used primers are shown in
Table 1. A hot start Taq polymerase (Hotstar Taq
Polymerase, Qiagen) was used. The annealing conditions
of the PCR reactions varied between 50 and 65 8C. The PCR
products were directly sequenced in both directions. The
obtained sequences were edited, aligned and analysed
using the software Bioedit (Hall, 1999). The obtained
sequences were compared to sequences available in
GenBank by performing BLAST searches. The deduced
amino acid sequences were compared to the proteins of
myxoma virus strain ‘‘Lausanne’’ and ‘‘6918’’.
2.3. Myxoma virus isolates
Nine field strains were obtained from European rabbits
displaying signs and/or lesions compatible with myxoma-
tosis. They were collected between 2004 and 2007 in
different locations in Portugal: four were obtained from
wild rabbits in the southern province Algarve (C43, C95,
C116, C152), three from wild rabbits in the north-eastern
province Tra´s-os-Montes e Alto Douro (CB31, CB32,
CB191), and two from an outbreak in domestic rabbits
in the north-western province Douro Litoral (CD01, CD05).
The vaccine strain ‘‘MAV’’ was originally derived from a cell
culture attenuated Californian myxoma MSD virus
(Mckercher and Saito, 1964). It is currently used as seed
for commercially available vaccines in Europe (Gorski
et al., 1994). This vaccine strain was kindly made available
by the company IDT Biologika GmbH, Dessau, Germany,
through the Friedrich-Loeffler-Institut, Germany, and was
used here as reference strain.
The diagnosis of myxomatosis was made by PCR
targeting the thymidine kinase gene (M061R) using DNA
extracts from eyelids (Table 1). In order to increment viral
yield for the genetic characterisation, the viruses were
passaged twice in RK-13 cells. Virus was harvested aftersubmitting the infected cell culture twice to freeze–thaw
cycles at80 8C. Cell-free supernatant was used for nucleic
acid extraction using the QIAamp Viral RNA Mini Kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions.
2.4. Nucleotide sequence accession numbers
The GenBank accession numbers of 16 sequences
representing the observed nucleotide changes are
FJ970492–FJ970507.
3. Results
Ten genomic regions spanning 12 genes were selected
for the partial genetic analysis of 9 virulent myxoma virus
field isolates obtained from 7 wild and 2 domestic rabbits
between 2004 and 2007 in Portugal, as well as from the
German live attenuated vaccine strain ‘‘MAV’’. The
sequence information on 4863 bp (corresponding to 3%
of the viral genome) was compared to that of strains
‘‘Lausanne’’ and ‘‘6918’’. We also confirmed the insertion of
the CTC codon in gene M020L of all field strains as well as
the vaccine strain (data not shown). The results are shown
in Table 2. Within gene M002L/R (907 bp) all field isolates
displayed one single nucleotide substitution, albeit at
three different locations. Six of the nine field strains
displayed a nonsynonymous substitution at position 1981,
which was also observed in strain ‘‘6918’’. The field strains
CB191 and CD01 showed a synonymous substitution at
position 1971. In field strain CD05, which originated from
the same outbreak as CD01, a nonsynonymous nucleotide
change at a different position (1975) was observed. The
vaccine strain was identical to ‘‘Lausanne’’. Within gene
M007L/R (735 bp), two nonsynonymous nucleotide sub-
stitutions were observed in field strain C43 and in the
vaccine strain (positions 8261 and 8494, respectively).
Within gene M009L (477 bp), five field strains (C95, C116,
CB31, CB32, CB191) displayed a single nucleotide insertion
(C) at position 12297 after a homopolymeric region of 5
cytosins, causing a frameshift after amino acid 280. The
PCR amplification of the vaccine strain yielded two very
weak bands of approximately 100 and 400 bp, inadequate
for successful sequencing. Within the region spanning
M014L/M015L (430 bp) a single nucleotide insertion (A)
was observed at position 16616 of the intergenic region of
six field strains (C43, C95, C116, CB31, CB32, CB191) after a
homopolymeric region of 10 adenosines. PCR amplification
of this region of the vaccine strain was unsuccessful. At
gene M022L (384 bp) all field strains were identical to
‘‘Lausanne’’ and the vaccine strain displayed eight synon-
ymous nucleotide substitutions. Within gene M036R
(229 bp), nonsynonymous nucleotide substitutions were
observed at positions 37588 and 37759, of the two field
strains C95 and C152, respectively. The vaccine strain
displayed 27 nucleotide substitution, of which 5 were
nonsynonymous. In gene M135R (229 bp), the same
nonsynonymous nucleotide substitution was observed at
position 131772 in the field strains CB31 and CB32. The
remaining, as well as the vaccine strain, were identical to
‘‘Lausanne’’. Within the region spanning M137R/138L
Table 2
Observed nucleotide polymorphisms and deduced amino acid variations in recent myxoma virus field strains. The nucleotide and amino acid positions refer tomyxoma virus strain ‘‘Lausanne’’ (GenBank accession
no. AF170726). The GenBank accession numbers of selected sequences (FJ970492–FJ970507) are indicated below the respective polymorphic nucleotide positions.
Terminal region Central region Terminal region
Gene M002L/R 907 bp M007L/R 735 bp M009L 477 bp M014L
M015L
430 bp
M022L 384 bp M036L 307 bp M135R 229 bp M137R/M138L
958 bp
M148R 436 bp
NT AA NT AA NT AA NT NT AA NT AA NT AA NT AA NT AA
Strain 6918
(EU552530)
T1981
A2497
T2594
D222
F104
S18
A8064 F238 Deletion
11942–
11951
F/S after
aa395
start Met
398
ID ID ID Insertion
C37687
F/S after
aa523
start Met
542
Insertion
G131750
F/S
after aa19
start Met
44
ID ID Deletionl
C142959
F/S after
aa446
start Met
505
C43 T1981
FJ970494
D222 A8261
FJ970496
ID ID ID IDa
FJ970498
ID ID ID ID ID ID ID ID G142867
FJ970506
S416
C95 T1981 D222 ID ID Insertion
C12297
FJ970497
F/S after
aa280
start Met
303
IDa ID ID T37588
FJ970500
M496 ID ID ID ID G142867 S416
C116 T1981 D222 ID ID Insertion
C12297
F/S after
aa280
start Met
303
IDa ID ID ID ID ID ID ID ID G142867 S416
C152 T1981 D222 ID ID ID ID ID ID ID T37759
FJ970501
M553 ID ID ID ID ID ID
CB31 T1981 D222 ID ID Insertion
C12297
F/S after
aa280
start Met
303
IDa ID ID ID ID T131772
FJ970503
C27 IDb
FJ970504
ID ID ID
CB32 T1981 D222 ID ID Insertion
C12297
F/S after
aa280
start Met
303
IDa ID ID ID ID T131772 C27 IDb ID ID ID
CB191 T1971
FJ970492
ID ID ID Insertion
C12297
F/S after
aa280
start Met
303
IDa ID ID ID ID ID ID A133966
FJ970505
C261 ID ID
CD01 T1971 ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID
CD05 C1975
FJ970495
G224 ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID
Vaccine strain
‘‘MAV’’
ID ID G8492
FJ970507
ID No PCR
amplicon
(2 weak
bands 100 +
400 kb
approx.)
– No PCR
amplicon
C23296
T23212
C23218
A23235
C23236
G23254
T23257
FJ970499
All ID 27 nt subst.
FJ970502
L458
S491
S530
S532
S549
All other 22
ID
ID ID ID ID T142804
FJ970493
V395
ID Identical to ‘‘Lausanne’’
F/S frameshift.
a Insertion (A) after nucleotide 16616 of a poly-A in the non-coding region.
b Point mutation (C! T) at position 133846 in the non-coding region.
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A. Muller et al. / Veterinary Microbiology 140 (2010) 161–166 165(958 bp), a nonsynonymous nucleotide substitution was
observed at position 133966 of field strain CB191, and a
single nucleotide substitution at position 133846 in the
intergenic non-coding region of strains CB31 and CB32.
Within gene M148R (436 bp), nonsynonymous nucleotide
substitutions were observed at position 142867 of isolates
C43, C95, C116, and at position 142804 of the vaccine
strain.
4. Discussion
Since the introduction of Myxoma virus into its new
host population, the European rabbit, a decrease in disease
mortality has been observed and myxomatosis has turned
into a frequently cited example of virus–host adaptation,
but genetic information on field strains is scarce (Kritas
et al., 2008; Morales et al., 2008; Saint et al., 2001). In the
present study only virulent virus strains were included,
because field evidence of attenuated or atypical forms of
disease is difficult to obtain, as these probably go
undetected, e.g. we were unable to find evidence of
myxoma virus infection in eyelid samples from 30 healthy
wild rabbits hunted in southern Portugal (Pancas) and
tested by PCR analysis of the TK gene as well as by three
consecutive passages on RK-13 cells (data not shown). The
analysed nucleotide sequences presented here corre-
sponded to only approximately 3% of the complete viral
genome, but they were selected based on the above-
mentioned criteria and thus considered good candidates
for detecting changes reflecting virus–host co-evolution.
Interestingly, a maximum of only three (strains C43, C95)
and a minimum of one nucleotide substitutions (strains
CD01, CD05) were observed in each field strain. The
attenuated strain ‘‘6918’’ only displayed four nucleotide
substitutions within the analysed genome regions, one of
which (position 1981 of gene M002L/R) was also found in
six of the field strains, suggesting that this mutation is
being fixed in some European wild rabbit populations. The
major envelope gene (M022L) ofmyxoma is exposed to the
rabbit’s immune system, and expected to be a good target
for identifying viral variability. Surprisingly, the analysed
gene sequences of the field isolates were identical to strain
‘‘Lausanne’’, similar to that of a pathogenic myxoma virus
isolated from an outbreak in vaccinated and non-vacci-
nated commercial rabbits in Greece (Kritas et al., 2008).
Within M022L of the vaccine strain, eight synonymous
nucleotide substitutions were found. No equivalent
sequence information on the MSD strain was found in
GenBank to understand whether these mutations are
characteristic for this strain, or whether they may reflect
pressures related to its attenuation process. Although our
findings support the limited degree of genetic alteration
found in recent myxoma virus field strains (Morales et al.,
2008; Saint et al., 2001), the mutations observed in the
selected genome regions allowed the individual identifica-
tion and some grouping of the strains according to their
geographic origin. For example, CB31 and CB32, which
were collected fromwild rabbits during the same occasion,
are identical to each other but differ from CB191, which
was sampled at a different geographic location, but also in
the north of Portugal. Interestingly the strains obtainedfrom domestic rabbits during an outbreak in a family farm
(CD01, CD05) displayed mutations at different locations of
gene M002L/R, but were otherwise identical to ‘‘Lau-
sanne’’.
Within myxoma viruses, whole gene gain or loss does
not seem to occur, but single or multiple base pair
insertions and deletions which resulted in frameshift
mutations have been described (Morales et al., 2008). We
have found two homopolymeric sites, where a single
nucleotide has been inserted in some of the virulent field
strains: within gene M009L and in the non-coding region
between M014L and M015L. Thus these single nucleotide
insertions do not seem to affect virulence. However, major
disruptions, at least in M009L, may indeed play an
important role in attenuation, e.g. in strain ‘‘6918’’
(Morales et al., 2008). Although it has been argued that
integrity of gene M009L may not be a critical virulence
factor in myxoma virus, because of its disruption in the
virulent Californian strain MSW (Labudovic et al., 2004)
and its partial duplication in the attenuated Shope fibroma
virus (Willer et al., 1999), it should be remembered,
however, that these leporipoxviruses have evolved in
different hosts, S. bachmani and S. floridanus, respectively,
whereas the natural host of myxoma virus is S. brasiliensis
(Fenner and Ross, 1994). They present a considerable
degree of genetic heterogeneity (84–89%) and may not
entirely be suitable for comparison with ‘‘Lausanne’’ and
‘‘6918’’. Major changes are likely to be present in gene
M009L of the vaccine strain, hampering PCR amplification
and yielding two products of smaller sizes. The use of two
other primer pairs overlapping the site of the deletion in
‘‘6918’’ (positions 11937–11947) was unsuccessful (not
shown). The region spanning genes M014L/M015L of the
vaccine strain could also not be amplified successfully,
suggesting the occurrence of genomic changes requiring
further investigations. Single indels in genes M135R and
M148R were considered of putative relevance for the
attenuation of ‘‘6918’’ (Morales et al., 2008). Our results
support this hypothesis as these changes were not
observed in the virulent field strains. However, they were
neither found in the vaccine strain, indicating that they are
not essential for attenuation. The disruption of another
gene (M135R) was considered a potentially important
determinant for the attenuation of the field strain ‘‘6918’’
(Morales et al., 2008). Again, this disruption does not seem
essential for attenuation, as it did not occur in the vaccine
strain. The sequence spanning genes m137R/m138L of the
vaccine strain displayed 100% nucleotide indentity with
‘‘Lausanne’’. This is rather unexpected, as the sequence
comparison with the ‘‘MSD’’ strain (Genbank accession no.
AF030894), from which the vaccine strain was derived,
displayed only 84% nucleotide identity to strain ‘‘Lau-
sanne’’. The vaccine strain has a long history of cell culture
passaging, and it is thus very difficult to rule out possible
cross-contaminations with ‘‘Lausanne’’-derived isolates or
strains at any point.
Altogether, these results support those obtained with
specific gene knockout viruses, in that various disruptions,
on their own or in synergy, may affect virulence of
myxoma viruses (Johnston and McFadden, 2003; Stanford
et al., 2007;Willer et al., 1999). Further field strains should
A. Muller et al. / Veterinary Microbiology 140 (2010) 161–166166be analysed to assess the frequency of single base
substitutions and indels as well as their importance in
reflecting viral evolutionary processes, also considering
that misincorporations due to polymerase infidelity (in
vivo and in vitro) may account for some of the observed
differences between strains. Although focussing on only
small parts of the viral genome, this study supports the
relatively high degree of genetic stability of myxoma field
strains over the past five decades (Saint et al., 2001;
Morales et al., 2008). Based on our findings it is difficult to
identify unique single genemarkers of virus attenuation or
evolution, indicating that analyses of larger portions of the
genome are required.
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